Preclinical Data Supporting/Refuting the Use of Hypericum perforatum in the Treatment of Depression

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|12|4|474-486

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.4, 2013-06, pp. : 474-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypericum Extract: Potential in the Treatment of Depression

By Wheatley D.  

CNS Drugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 431-440

Adis International

Access to resources Recommend Favorite

Sub-chronic treatment with an extract of Hypericum perforatum (St John's wort) significantly reduces cortisol and corticosterone in the rat brain

By Franklin M.   Reed A.   Murck H.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 7-10

Elsevier

Access to resources Recommend Favorite

The Efficacy of Hypericum perforatum (St John's Wort) for the Treatment of Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

By Canning Sarah  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 207-225

Adis International

Access to resources Recommend Favorite

Preclinical discovery of duloxetine for the treatment of depression

By Torres-Sanchez Sonia   Perez-Caballero Laura   Mico Juan Antonio   Elorza Julian   Berrocoso Esther  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 8, 2012-08 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

Hypericum perforatum, a Source of Neuroactive Lead Structures

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 2, 2003-01 ,pp. : 187-201

Bentham Science Publishers

Access to resources Recommend Favorite